Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The neurovascular unit in health and disease: introduction.

Literature DB >> 19064779

The neurovascular unit in health and disease: introduction.

Eng H Lo¹, Gary A Rosenberg.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2008 PMID： 19064779 PMCID： PMC2811575 DOI： 10.1161/STROKEAHA.108.534404

Source DB: PubMed Journal: Stroke ISSN： 0039-2499 Impact factor: 7.914

× No keyword cloud information.

14 in total

1. Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation.

Authors: Kate J Gurney; Eduardo Y Estrada; Gary A Rosenberg
Journal: Neurobiol Dis Date: 2006-04-19 Impact factor: 5.996

Review 2. The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors: Berislav V Zlokovic
Journal: Neuron Date: 2008-01-24 Impact factor: 17.173

3. Blood-brain barrier dysfunction in Binswanger's disease; an immunohistochemical study.

Authors: I Akiguchi; H Tomimoto; T Suenaga; H Wakita; H Budka
Journal: Acta Neuropathol Date: 1998-01 Impact factor: 17.088

4. Brain endothelial hemostasis regulation by pericytes.

Authors: Jeong Ai Kim; Nam D Tran; Zhen Li; Fan Yang; Weilin Zhou; Mark J Fisher
Journal: J Cereb Blood Flow Metab Date: 2006-02 Impact factor: 6.200

Review 5. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?

Authors: J M Wardlaw; P A G Sandercock; M S Dennis; J Starr
Journal: Stroke Date: 2003-02-27 Impact factor: 7.914

6. Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ.

Authors: Ping Yan; Xiaoyan Hu; Haowei Song; Kejie Yin; Randall J Bateman; John R Cirrito; Qingli Xiao; Fong F Hsu; John W Turk; Jan Xu; Chung Y Hsu; David M Holtzman; Jin-Moo Lee
Journal: J Biol Chem Date: 2006-06-20 Impact factor: 5.157

7. White matter damage is associated with matrix metalloproteinases in vascular dementia.

Authors: G A Rosenberg; N Sullivan; M M Esiri
Journal: Stroke Date: 2001-05 Impact factor: 7.914

8. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease.

Authors: John C Adair; Julius Charlie; John E Dencoff; Jeffrey A Kaye; Joseph F Quinn; Richard M Camicioli; William G Stetler-Stevenson; Gary A Rosenberg
Journal: Stroke Date: 2004-04-22 Impact factor: 7.914

9. Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons.

Authors: Shuzhen Guo; Woo Jean Kim; Josephine Lok; Sun-Ryung Lee; Elaine Besancon; Bing-Hao Luo; Monique F Stins; Xiaoying Wang; Shoukat Dedhar; Eng H Lo
Journal: Proc Natl Acad Sci U S A Date: 2008-05-21 Impact factor: 11.205

Review 10. Multiple roles for MMPs and TIMPs in cerebral ischemia.

Authors: Lee Anna Cunningham; Monica Wetzel; Gary A Rosenberg
Journal: Glia Date: 2005-06 Impact factor: 8.073

64 in total

1. Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice.

Authors: Kazunori Miyazaki; Kazuto Masamoto; Nobutoshi Morimoto; Tomoko Kurata; Takahumi Mimoto; Takayuki Obata; Iwao Kanno; Koji Abe
Journal: J Cereb Blood Flow Metab Date: 2011-11-09 Impact factor: 6.200

The neurovascular unit in health and disease: introduction.

1. Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation.

Review 2. The blood-brain barrier in health and chronic neurodegenerative disorders.

3. Blood-brain barrier dysfunction in Binswanger's disease; an immunohistochemical study.

4. Brain endothelial hemostasis regulation by pericytes.

Review 5. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?

6. Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ.

7. White matter damage is associated with matrix metalloproteinases in vascular dementia.

8. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease.

9. Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons.

Review 10. Multiple roles for MMPs and TIMPs in cerebral ischemia.

1. Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice.

2. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging.

3. Neurovascular-glymphatic dysfunction and white matter lesions.

4. Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke Victims.

5. Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.

6. A Dual Role for Hyperbaric Oxygen in Stroke Neuroprotection: Preconditioning of the Brain and Stem Cells.

Review 7. Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: An aging effect.

Review 8. Pharmaco-proteomics opportunities for individualizing neurovascular treatment.

9. PHLPP1 gene deletion protects the brain from ischemic injury.

10. Following experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signaling.